Dec. 22, 2017
Cochlear Ltd Announces Research Study Collaboration, and $1.9M Placement, with Sensorion
SYDNEY, AUSTRALIA — Hearing implant maker, Cochlear Ltd, announced a strategic collaboration with French biotech firm, Sensorion. The collaboration will examine therapeutic approaches using Sensorion’s investigative drug, SENS-401, in combination with cochlear implants. According to the press release, the preclinical studies will be initiated in 2018, with possible clinical trials beginining as early as 2019. Cochlear will invest €1.6 million